oxybutynin has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laustsen, G; Wimett, L | 1 |
| Holder, T; Indes, JE; Muhs, B; Ochoa Chaar, CI; Rajaee, S; Sarac, T; Sumpio, B; Toll, BA | 1 |
1 review(s) available for oxybutynin and cardiovascular agents
| Article | Year |
|---|---|
Drug approval highlights for 2003.
Topics: Acyclovir; Cardiovascular Agents; Cardiovascular Diseases; Dermatologic Agents; Drug Approval; Estrogen Replacement Therapy; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Immunologic Factors; Male; Mandelic Acids; Skin Diseases; Valacyclovir; Valine; Women's Health | 2004 |
1 trial(s) available for oxybutynin and cardiovascular agents
| Article | Year |
|---|---|
A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease.
Topics: Aneurysm; Cardiovascular Agents; Cholinergic Agents; Connecticut; Endovascular Procedures; Female; Humans; Male; Middle Aged; Nicotine; Patient Education as Topic; Peripheral Arterial Disease; Pilot Projects; Risk Factors; Risk Reduction Behavior; Smokers; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Transdermal Patch; Treatment Outcome; Vascular Surgical Procedures | 2019 |